Focusing on the Opioid System for Addiction Biomarker Discovery.

TitleFocusing on the Opioid System for Addiction Biomarker Discovery.
Publication TypeJournal Article
Year of Publication2018
AuthorsBelzeaux R, Lalanne L, Kieffer BL, Lutz P-E
JournalTrends Mol Med
Volume24
Issue2
Pagination206-220
Date Published2018 Feb
ISSN1471-499X
Abstract

Substance use disorders (SUD) and behavioral addictions are devastating conditions that impose a severe burden on all societies, and represent difficult challenges for clinicians. Therefore, biomarkers are urgently needed to help predict vulnerability, clinical course, and response to treatment. Here, we elaborate on the potential for addiction biomarker discovery of the opioid system, particularly within the emerging framework aiming to probe opioid function in peripheral tissues. Mu, delta, and kappa opioid receptors all critically regulate neurobiological and behavioral processes that define addiction, and are also targeted by major pharmacotherapies used in the management of patients with SUD. We propose that opioid biomarkers may have the potential to improve and guide diagnosis and therapeutic decisions in the addiction field.

DOI10.1016/j.molmed.2017.12.004
Alternate JournalTrends Mol Med
PubMed ID29396147

McGill Logo

CIUSSS ouest montreal logo

 



  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre